A Novel Mechanism Underlying Antiviral Activity of an Influenza Virus M2-Specific Antibody

  • Rashid Manzoor
    Division of Global Epidemiology, Research Center for Zoonosis Control, Hokkaido University, Sapporo, Japan
  • Nao Eguchi
    Division of Global Epidemiology, Research Center for Zoonosis Control, Hokkaido University, Sapporo, Japan
  • Reiko Yoshida
    Division of Global Epidemiology, Research Center for Zoonosis Control, Hokkaido University, Sapporo, Japan
  • Hiroichi Ozaki
    Faculty of Agriculture, School of Veterinary Medicine, Tottori University, Tottori, Japan
  • Tatsunari Kondoh
    Division of Global Epidemiology, Research Center for Zoonosis Control, Hokkaido University, Sapporo, Japan
  • Kosuke Okuya
    Division of Global Epidemiology, Research Center for Zoonosis Control, Hokkaido University, Sapporo, Japan
  • Hiroko Miyamoto
    Division of Global Epidemiology, Research Center for Zoonosis Control, Hokkaido University, Sapporo, Japan
  • Ayato Takada
    Division of Global Epidemiology, Research Center for Zoonosis Control, Hokkaido University, Sapporo, Japan

Search this article

Description

<jats:p>Although the IAV HA is the major target of neutralizing antibodies, most of the antibodies are HA subtype specific, restricting the potential of HA-based vaccines. On the contrary, the IAV M2 protein has been studied as a vaccine antigen to confer cross-protective immunity against IAVs with multiple HA subtypes, since M2 is antigenically conserved. Although a number of studies highlight the protective role of anti-HA neutralizing and nonneutralizing antibodies, precise information on the molecular mechanism of action of M2-specific antibodies is still obscure. In this study, we found that an anti-M2 antibody interfered with the HA-M2 association, which is important for efficient budding of progeny virus particles from infected cells. The antiviral activity was IAV strain dependent despite the similar binding capacity of the antibody to M2, and, interestingly, HA was involved in susceptibility to the antibody. Our data provide a novel mechanism underlying antiviral activity of M2-specific antibodies.</jats:p>

Journal

References(54)*help

See more

Related Projects

See more

Details 詳細情報について

Report a problem

Back to top